<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The study aimed to assess the relative importance of the control of HbA(1c) and total cholesterol/<z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> ratio (TC/<z:chebi fb="17" ids="39025">HDL</z:chebi>) on risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In 22,135 participants with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (age 30-75 years, 15% with previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) followed for 5 years, baseline and annually updated mean HbA(1c) and TC/<z:chebi fb="17" ids="39025">HDL</z:chebi> were analysed and also categorised in combinations of quartiles </plain></SENT>
<SENT sid="2" pm="."><plain>Outcomes were fatal/non-fatal CHD, <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and total mortality </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In <z:hpo ids='HP_0000001'>all</z:hpo> participants, HRs per 1 SD increase in updated mean HbA(1c) or TC/<z:chebi fb="17" ids="39025">HDL</z:chebi> using Cox regression analysis were 1.13 (95% CI 1.07, 1.19) and 1.31 (1.25, 1.37) for CHD, 1.15 (1.06, 1.24) and 1.25 (1.17, 1.34) for <z:hpo ids='HP_0001297'>stroke</z:hpo>, 1.13 (1.08, 1.18) and 1.29 (1.24, 1.34) for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> p &lt; 0.001), and 1.07 (1.02, 1-13; p = 0.01) and 1.18 (1.12, 1.24; p &lt; 0.001) for total mortality, respectively, adjusted for clinical characteristics and traditional risk factors </plain></SENT>
<SENT sid="4" pm="."><plain>The p value for the interaction between HbA(1c) and TC/<z:chebi fb="17" ids="39025">HDL</z:chebi> was 0.02 for CHD, 0.6 for <z:hpo ids='HP_0001297'>stroke</z:hpo> and 0.1 for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Adjusted mean 5-year event rates in a Cox model, in combinations of quartiles of updated mean TC/<z:chebi fb="17" ids="39025">HDL</z:chebi> and HbA(1c) (lowest &lt;3.1 mmol/l and 5.0-6.4% [31-46 mmol/mol]; &lt;3.1 mmol/l and ≥7.8% [≥62 mmol/mol]; ≥4.6 mmol/l and 5.0-6.4% 31-46 mmol/mol; and highest ≥4.6 mmol/l and ≥7.8% [≥62 mmol/mol]), were 4.8%, 7.0%, 9.1% and 14.5% for CHD, and 7.1%, 9.9%, 12.8% and 19.4% for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Adjusted HRs for highest vs lowest combinations were 2.24 (1.58-3.18) for CHD and 2.43 (1.79-3.29) for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">Hyperglycaemia</z:e> and <z:e sem="disease" ids="C0020473" disease_type="Disease or Syndrome" abbrv="">hyperlipidaemia</z:e> were less than additive for CHD and additive for other endpoints, with the lowest risk at lowest combination levels and a considerable increase in absolute risk at high combination levels </plain></SENT>
</text></document>